{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T11:13:55Z","timestamp":1777806835548,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007847","name":"Jilin Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["YDZJ202201ZYTS288"],"award-info":[{"award-number":["YDZJ202201ZYTS288"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.imlet.2025.107061","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:39:43Z","timestamp":1752579583000},"page":"107061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Elevated ascitic interleukin-36 receptor antagonist mediates CD8+ T cell exhaustion in vitro in liver cirrhotic patients with spontaneous bacterial peritonitis"],"prefix":"10.1016","volume":"276","author":[{"given":"Lanlan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6210-4526","authenticated-orcid":false,"given":"Zhenjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2025.107061_bib0001","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2025.107061_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2024.100116","article-title":"Multiomic predictors for regression of cirrhosis: clinical implications and future directions","volume":"3","author":"Li","year":"2024","journal-title":"iLiver"},{"key":"10.1016\/j.imlet.2025.107061_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108729","article-title":"Overexpression of ascitic interleukin-35 induces CD8(+) T cell exhaustion in liver cirrhotic patients with spontaneous bacterial peritonitis","volume":"108","author":"Yang","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.imlet.2025.107061_bib0004","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imlet.2025.107061_bib0005","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMra2021808","article-title":"The evolving challenge of infections in cirrhosis","volume":"384","author":"Bajaj","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2025.107061_bib0006","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imlet.2025.107061_bib0007","doi-asserted-by":"crossref","first-page":"16795","DOI":"10.3748\/wjg.v20.i45.16795","article-title":"Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis","volume":"20","author":"Giannelli","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.imlet.2025.107061_bib0008","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imlet.2025.107061_bib0009","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.aohep.2020.04.010","article-title":"Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis","volume":"19","author":"Mattos","year":"2020","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.imlet.2025.107061_bib0010","first-page":"345","article-title":"Spontaneous bacterial peritonitis: update on diagnosis and treatment","volume":"59","author":"Popoiag","year":"2021","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.imlet.2025.107061_bib0011","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2025.107061_bib0012","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00281-019-00744-5","article-title":"CD8(+) T cell exhaustion","volume":"41","author":"Kurachi","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imlet.2025.107061_bib0013","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.imlet.2025.107061_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8(+) T Cell Exhaustion in Cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107061_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2025.107061_bib0016","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.imlet.2025.107061_bib0017","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.imlet.2025.107061_bib0018","doi-asserted-by":"crossref","first-page":"28","DOI":"10.14712\/fb2021067010028","article-title":"Serum cytokine analysis reveals predictors of progression from chronic hepatitis B to liver cirrhosis","volume":"67","author":"Cai","year":"2021","journal-title":"Folia Biol. (Praha)"},{"key":"10.1016\/j.imlet.2025.107061_bib0019","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1080\/09546634.2022.2067819","article-title":"A review of IL-36: an emerging therapeutic target for inflammatory dermatoses","volume":"33","author":"Hwang","year":"2022","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.imlet.2025.107061_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jid.2023.11.004","article-title":"Emerging role of the IL-36\/IL-36R axis in multiple inflammatory skin diseases","volume":"144","author":"Ahmad","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2025.107061_bib0021","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4049\/jimmunol.2100481","article-title":"The protective role of IL-36\/IL-36R signal in Con A-induced acute hepatitis","volume":"208","author":"Wang","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107061_bib0022","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1038\/srep08521","article-title":"Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury","volume":"5","author":"Scheiermann","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2025.107061_bib0023","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3389\/fimmu.2019.01803","article-title":"IL-36beta promotes CD8(+) T cell activation and antitumor immune responses by activating mTORC1","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107061_bib0024","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/vim.2023.0080","article-title":"Interleukin-36gamma mediates the In Vitro activation of CD8(+) T cells from patients living with chronic human immunodeficiency virus-1 infection","volume":"37","author":"Zhou","year":"2024","journal-title":"Viral. Immunol."},{"key":"10.1016\/j.imlet.2025.107061_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111513","article-title":"Interleukin-36 receptor antagonist stimulation in vitro inhibits peripheral and lung-resident T cell response isolated from patients with ventilator-associated pneumonia","volume":"129","author":"Xin","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imlet.2025.107061_bib0026","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.3748\/wjg.v21.i41.11567","article-title":"Non-invasive diagnosis of liver fibrosis and cirrhosis","volume":"21","author":"Lurie","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.imlet.2025.107061_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"70","author":"Aithal","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.imlet.2025.107061_bib0028","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.micpath.2017.11.023","article-title":"Elevated production of IL-36alpha in chronic hepatitis B virus-infected patients correlates with viral load","volume":"113","author":"Gong","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.imlet.2025.107061_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1194733","article-title":"Interleukin-36gamma is causative for liver damage upon infection with Rift Valley fever virus in type I interferon receptor-deficient mice","volume":"14","author":"Anzaghe","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107061_bib0030","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1111\/bph.15858","article-title":"Modulation of interleukin-36 based inflammatory feedback loop through the hepatocyte-derived IL-36R-P2X7R axis improves steatosis in alcoholic steatohepatitis","volume":"179","author":"Shang","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imlet.2025.107061_bib0031","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.1800046","article-title":"Opposing effects of IL-1Ra and IL-36Ra on innate immune response to pseudomonas aeruginosa infection in C57BL\/6 mouse corneas","volume":"201","author":"Gao","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107061_bib0032","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107061_bib0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cyto.2016.05.023","article-title":"IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose-dependently activated via IL-36beta and induces CD4+ lymphocyte proliferation","volume":"85","author":"Penha","year":"2016","journal-title":"Cytokine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782500094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782500094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:47:48Z","timestamp":1777495668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524782500094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S016524782500094X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107061","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated ascitic interleukin-36 receptor antagonist mediates CD8+ T cell exhaustion in vitro in liver cirrhotic patients with spontaneous bacterial peritonitis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107061"}}